Matches in Nanopublications for { ?s ?p "[Noncirrhotic HCV treatment-naive patients and prior relapsers received response-guided therapy (RGT) with peg-IFN/RBV for 24 or 48 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Noncirrhotic HCV treatment-naive patients and prior relapsers received response-guided therapy (RGT) with peg-IFN/RBV for 24 or 48 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Noncirrhotic HCV treatment-naive patients and prior relapsers received response-guided therapy (RGT) with peg-IFN/RBV for 24 or 48 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1217311.RA4Y-wEnIdzJqiAZGFPhNR77A4z00My49YZXz-xWrerQA130_assertion description "[Noncirrhotic HCV treatment-naive patients and prior relapsers received response-guided therapy (RGT) with peg-IFN/RBV for 24 or 48 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217311.RA4Y-wEnIdzJqiAZGFPhNR77A4z00My49YZXz-xWrerQA130_provenance.
- NP1217313.RAyDBt59N5r48mSjtSivoTOCa9OrHfHPB4TX65Pk-J63U130_assertion description "[Noncirrhotic HCV treatment-naive patients and prior relapsers received response-guided therapy (RGT) with peg-IFN/RBV for 24 or 48 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217313.RAyDBt59N5r48mSjtSivoTOCa9OrHfHPB4TX65Pk-J63U130_provenance.